Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
NCT Number: NCT00617006
We hypothesized that by improving hand hygiene compliance in the operative environment, we would reduce horizontal transmission of pathogenic bacteria to surgical patients.
Looking for future studies?
Notify MeAll sexes
Observational
Lebanon, New Hampshire, 03756, United States
We performed an observational study evaluating provider adherence to these techniques. We then sought to increase hand hygiene compliance through the use of a point of care alcohol based hand hygiene device. We hypothesized that increased hand hygiene compliance would reduce bacterial contamination of the anesthesia workspace and peripheral intravenous tubing, and ultimately reducing overall morbidity and mortality secondary to a reduction in nosocomial infection rates.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Beginning and end of surgical case
Time frame: Beginning and End of Surgical Case
Time frame: Postoperatively
Time frame: within 30 days postoperatively
Time frame: Within 30 days postoperatively
Dartmouth-Hitchcock Medical Center
Other
Before and After Study Evaluating Deployment of the Sprixx GJ Personal Hand Hygiene Device in the Intra-Operative Environment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01338116
Community-associated Infections, Cross Infection
Petah Tikvah, Israel
View Trial DetailsNCT04748432
Cross Infection, Disease Attributes
Konya, Turkey (Türkiye)
View Trial DetailsNCT02600195
Cross Infection, Disease Attributes
Hefei, Anhui, China
View Trial DetailsNCT00549393
Cross Infection, Disease Attributes
Washington D.C., District of Columbia, United States
View Trial Details